Developing Applications and Expanding the Market for the Immobilized Antimicrobial Agent Etak
First written in FY2022. 2 of 4 entries say "Restated". Latest entry: FY2023-Q3.
No other company in this theme has enough history to compare yet.
- FY2023-Q3RestatedAnnual report
「Demand for the immobilized antimicrobial agent “Etak®,” jointly developed and commercialized with Hiroshima University and patented, has also levelled off.」
The Company continues to report that demand for the immobilized antimicrobial agent Etak has levelled off. It did not state that its initiatives for application development and market expansion had been withdrawn. - FY2023-Q2RestatedAnnual report
「Demand for the immobilized antimicrobial agent “Etak®,” jointly developed and commercialized with Hiroshima University and patented, has also levelled off.」
The Company continues to report that demand for the immobilized antimicrobial agent Etak has levelled off. It did not state that its initiatives for application development and market expansion had been withdrawn. - FY2023-Q1Demand growth has levelled offAnnual report
「Demand for the immobilized antimicrobial agent “Etak®,” jointly developed and commercialized with Hiroshima University and patented, has also levelled off.」
The Company reported that demand for the immobilized antimicrobial agent Etak had levelled off. It did not state that its initiatives for application development and market expansion had been withdrawn. - FY2022First statedAnnual report
「As part of the development of new businesses in the health-support business, we are actively pursuing application development aimed at expanding the market for the long-lasting immobilized antimicrobial ingredient “Etak®,” jointly developed and patented with Professor Hiroki Futagawa (二川 浩樹) of the Graduate School of Biomedical and Health Sciences (Dentistry), Hiroshima University, and the new disinfectant and antimicrobial coating agent “Etak® Safety Coat®,” which contains this ingredient.」
The Company is pursuing market expansion through application development for the patented immobilized antimicrobial ingredient and coating agent.